D. Veale et al., Mortality of sleep apnoea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory, EUR RESP J, 15(2), 2000, pp. 326-331
The aim of this study was to examine risk factors for and causes of mortali
ty in patients with obstructive sleep apnoea syndrome (OSAS) treated by nas
al continuous positive airway pressure (CPAP).
Univariate and multivariate analyses of the data on patients registered in
the Association Nationale pour le Traitement A Domicile de l'Insuffisance R
espiratoire chronique (ANTADIR) observatory between January 1, 1985 and Dec
ember 31, 1993 and followed to January 1, 1996, Survival ratios were compar
ed to those of the French population. A case control study compared patient
s who died with patients of the same age and sex, in the same Regional Asso
ciation, who were equipped with CPAP at the same time. Five-thousand-six-hu
ndred-and-sixty-nine patients had CPAP treatment. Two-hundred-and-seventy-s
ix had died. One-hundred-and-twenty-four deaths were examined and compared
to 123 control subjects.
Overall mortality was, the same as the general French population. Independe
nt risk factors for death were age, oxygen tension in arterial blood (Pa,O-
2) and forced expiratory volume in one second (FEV1) (per cent predicted).
In the case-control study independent risk factors for death in the past hi
story were cardiac arrhythmia with an odds ratio (OR) of 2.8 (95% confidenc
e interval (CI) 1.1-7.2), respiratory disorders (OR 2.8; CI 1.6-;4.9) ischa
emic events (OR 2.2; CI 1.2-4.2), neurological and psychiatric disorders (O
R 2.4; Cf 1.1-5.4). A significant excess of cardiovascular deaths and an ex
cess of deaths from accidents and poisonings was found.
In conclusion, patients die on therapy predominantly from cardiovascular ca
uses but many have a past history of cardiovascular conditions. Compliance
with treatment may be important for survival. Continuous positive airway pr
essure is an effective therapy for obstructive sleep apnoea syndrome but ol
der patients with reduced spirometry and hypoxaemia may need more attention
paid to these aspects of their condition.